In the high-stakes world of clinical trials, there is a pervasive misconception among executives that "more sites" and "big-name institutions" are the silver bullets for meeting enrollment deadlines. The logic seems sound: partner with a subject matter expert at a world-renowned hospital to gain instant credibility and access to vast patient pools.

Securing government funding is a major milestone for any life sciences company—preserving runway and validating your science. But why does the transition to active clinical execution so often lead to gridlock?

In this edition of the CRO Consulting Interview Series, Dr. Glenn Harnett discusses building a high-performing SMO, scaling decentralized clinical trials, and expanding patient access through community-based IVD research.

Once considered the future of healthcare, precision medicine is now reshaping clinical trials. This blog explores how biomarker-driven development is changing trial design and what it means for sponsors and CROs.

FDA BIMO inspections can occur at any stage of development. Are you truly inspection-ready? This guide outlines what inspectors evaluate and how sponsors and CROs can strengthen compliance, oversight, and data integrity.

Decentralized clinical trials require more than technology — they demand intentional engagement strategies. Explore practical approaches to improving patient compliance, oversight, and retention in DCTs.

Dr. Mark J. Sarno shares insights from over 40 years in biostatistics, exploring how data drives innovation across clinical research, diagnostics, and drug development.

Delays are inevitable in clinical trials, but they don’t have to derail your study. Learn key strategies CRO Consulting has used to manage timelines successfully, strengthen collaboration, and ensure patients gain timely access to innovative therapies.

Explore how integrating behavioral science and patient-centered strategies can improve engagement and retention in obesity trials—where high dropout rates and easy access to weight loss meds pose growing challenges. Discover actionable ways sponsors can design more empathetic, effective studies.

The FDA’s first AI-assisted scientific review pilot is more than a tech milestone—it’s a signal of evolving regulatory expectations. Learn how this shift may impact submission strategies, data readiness, and the future of drug review.

A strong clinical trial budget is essential for keeping studies on time, in scope, and compliant. At CRO Consulting, we help Sponsors move beyond spreadsheets to build budgets that support real-world execution. This post covers key cost areas like site fees, vendor support, patient recruitment, and regulatory planning to help you prepare for trial success.

Ensure a smooth clinical trial process with these five key steps, from investigator training to data management. Learn how CRO Consulting can help you avoid costly delays and streamline your trial operations.

Curious about SEED funding but unsure where to begin? Discover the key differences between SBIR and STTR, and how CRO Consulting can guide you through every step of your funding journey!

Tips for a successful clinical trial